Timing Considerations for Noninvasive Vagal Nerve Stimulation in Clinical Studies - PubMed
- ️Wed Jan 01 2020
Clinical Trial
. 2020 Mar 4:2019:1061-1070.
eCollection 2019.
Affiliations
- PMID: 32308903
- PMCID: PMC7153149
Clinical Trial
Timing Considerations for Noninvasive Vagal Nerve Stimulation in Clinical Studies
Nil Z Gurel et al. AMIA Annu Symp Proc. 2020.
Abstract
Noninvasive vagal nerve stimulation (n-VNS) devices have the potential for widespread applicability in improving the well-being of patients with stress-related psychiatric disorders. n-VNS devices are known to affect physiological signals, and, recently, they have been employed in various protocols involving both acute and longitudinal applications. However, questions regarding response time, "dosage," or optimal treatment paradigms remain open. Prior work evaluated noninvasively obtained biomarkers that quantify the stimulation efficacy based on the changes in autonomic tone in a randomized double-blind study. In this work, we extend the state-of-the-art by investigating the onset of action for n-VNS in these same physiological biomarkers through a three-day clinical trial, including 233 administrations on 24 human participants, with and without immediately preceding acute traumatic stress. Determining n-VNS latency serves as a substantial step toward optimizing stimulation delivery with higher temporal resolution for personalized neuromodulation.
©2019 AMIA - All rights reserved.
Figures

Simplified representation of n-VNS mechanism of action. The understanding of n-VNS kinetics on noninvasively obtained physiological parameters may enable optimization of n-VNS delivery in unsupervised settings. NTS: nucleus tractus solitarus.

Protocol diagram. The protocol included three days: the first day included six traumatic stress prompts followed by immediate n-VNS or sham stimulation and two stimulation administrations without stress. Each of the second and third days included one stimulation administration without stress.

Signal processing and feature extraction steps. BPF: bandpass filter; exp. MA: exponential moving average; EA: ensemble average; AO: aortic opening point; PEP: pre-ejection period; HR: heart rate.

Annotation diagram. The smoothed instantaneous biomarkers (HR, PEP, PPG amplitude) were plotted from pre-stimulus to post-stimulus. If at least two of the three mentioned changes in the biomarkers occurred, the onset time was marked at the onset of the second change. If no eligible change was observed, the annotation was marked as “absent.”

Continuous physiological parameters showing n-VNS without traumatic stress, for one participant undergoing sham (left) and one participant undergoing active n-VNS stimulus (right). Markers represent the extracted data, lines represent the smoothed data. Shaded regions represent stimulus delivery. Dashed lines show the pre-stimulus averages of the measures. The onset time is marked as soon as two of the three annotation criteria mentioned in Figure 4 are detected.
Similar articles
-
Gurel NZ, Huang M, Wittbrodt MT, Jung H, Ladd SL, Shandhi MMH, Ko YA, Shallenberger L, Nye JA, Pearce B, Vaccarino V, Shah AJ, Bremner JD, Inan OT. Gurel NZ, et al. Brain Stimul. 2020 Jan-Feb;13(1):47-59. doi: 10.1016/j.brs.2019.08.002. Epub 2019 Aug 6. Brain Stimul. 2020. PMID: 31439323 Free PMC article. Clinical Trial.
-
Beaumont E, Campbell RP, Andresen MC, Scofield S, Singh K, Libbus I, KenKnight BH, Snyder L, Cantrell N. Beaumont E, et al. Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H354-H367. doi: 10.1152/ajpheart.00070.2017. Epub 2017 May 5. Am J Physiol Heart Circ Physiol. 2017. PMID: 28476920 Free PMC article.
-
Recent advances in devices for vagus nerve stimulation.
Mertens A, Raedt R, Gadeyne S, Carrette E, Boon P, Vonck K. Mertens A, et al. Expert Rev Med Devices. 2018 Aug;15(8):527-539. doi: 10.1080/17434440.2018.1507732. Epub 2018 Aug 17. Expert Rev Med Devices. 2018. PMID: 30071175 Review.
-
Technical Note: Modulation of fMRI brainstem responses by transcutaneous vagus nerve stimulation.
Borgmann D, Rigoux L, Kuzmanovic B, Edwin Thanarajah S, Münte TF, Fenselau H, Tittgemeyer M. Borgmann D, et al. Neuroimage. 2021 Dec 1;244:118566. doi: 10.1016/j.neuroimage.2021.118566. Epub 2021 Sep 10. Neuroimage. 2021. PMID: 34509623
-
Effects of vagal neuromodulation on feeding behavior.
Pelot NA, Grill WM. Pelot NA, et al. Brain Res. 2018 Aug 15;1693(Pt B):180-187. doi: 10.1016/j.brainres.2018.02.003. Epub 2018 Feb 7. Brain Res. 2018. PMID: 29425906 Free PMC article. Review.
Cited by
-
Gazi AH, Gurel NZ, Richardson KLS, Wittbrodt MT, Shah AJ, Vaccarino V, Bremner JD, Inan OT. Gazi AH, et al. JMIR Mhealth Uhealth. 2020 Sep 22;8(9):e20488. doi: 10.2196/20488. JMIR Mhealth Uhealth. 2020. PMID: 32960179 Free PMC article. Clinical Trial.
-
Bremner JD, Wittbrodt MT, Gurel NZ, Shandhi MH, Gazi AH, Jiao Y, Levantsevych OM, Huang M, Beckwith J, Herring I, Murrah N, Driggers EG, Ko YA, Alkhalaf ML, Soudan M, Shallenberger L, Hankus AN, Nye JA, Park J, Woodbury A, Mehta PK, Rapaport MH, Vaccarino V, Shah AJ, Pearce BD, Inan OT. Bremner JD, et al. J Affect Disord Rep. 2021 Dec;6:100190. doi: 10.1016/j.jadr.2021.100190. Epub 2021 Jul 10. J Affect Disord Rep. 2021. PMID: 34778863 Free PMC article.
-
Gurel NZ, Wittbrodt MT, Jung H, Ladd SL, Shah AJ, Vaccarino V, Bremner JD, Inan OT. Gurel NZ, et al. IEEE J Biomed Health Inform. 2020 Jul;24(7):1917-1925. doi: 10.1109/JBHI.2020.2981116. Epub 2020 Mar 16. IEEE J Biomed Health Inform. 2020. PMID: 32175881 Free PMC article.
-
Gurel NZ, Jiao Y, Wittbrodt MT, Ko YA, Hankus A, Driggers EG, Ladd SL, Shallenberger L, Murrah N, Huang M, Haffar A, Alkhalaf M, Levantsevych O, Nye JA, Vaccarino V, Shah AJ, Inan OT, Bremner JD, Pearce BD. Gurel NZ, et al. Compr Psychoneuroendocrinol. 2020 Oct 27;4:100012. doi: 10.1016/j.cpnec.2020.100012. eCollection 2020 Nov. Compr Psychoneuroendocrinol. 2020. PMID: 35755625 Free PMC article.
-
Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.
Bremner JD, Gazi AH, Lambert TP, Nawar A, Harrison AB, Welsh JW, Vaccarino V, Walton KM, Jaquemet N, Mermin-Bunnell K, Mesfin H, Gray TA, Ross K, Saks G, Tomic N, Affadzi D, Bikson M, Shah AJ, Dunn KE, Giordano NA, Inan OT. Bremner JD, et al. Ann Depress Anxiety. 2023;10(1):1117. Epub 2023 Aug 2. Ann Depress Anxiety. 2023. PMID: 38074313 Free PMC article.
References
-
- George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000;47((4)):287–95. - PubMed
-
- Campanella C, Bremner JD. Neuroimaging of PTSD. In: Bremner JD, editor. Posttraumatic Stress Disorder: From Neurobiology to Treatment. Hoboken, New Jersey: Wiley-Blackwell. 2016:291–320.
-
- Guiraud D, Andreu D, Bonnet S, Carrault G, Couderc P, Hagege A, et al. Vagus nerve stimulation: state of the art of stimulation and recording strategies to address autonomic function neuromodulation. J Neural Eng. 2016;13((4)):041002. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical